Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,826 | -13,074 | -10,213 | -6,433 | -28,074 |
| Depreciation Amortization | 231 | 170 | 107 | 46 | 235 |
| Accounts receivable | -316 | -195 | -89 | -469 | N/A |
| Accounts payable and accrued liabilities | 399 | 674 | 815 | 171 | N/A |
| Other Working Capital | 744 | -86 | 237 | 2,452 | -2,360 |
| Other Operating Activity | 1,891 | 1,177 | 585 | 910 | 18,107 |
| Operating Cash Flow | $-14,877 | $-11,334 | $-8,558 | $-3,323 | $-12,092 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,248 | 10,111 | 6,766 | 1,300 | N/A |
| PPE Investments | -115 | -115 | -109 | -27 | -156 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 69 |
| Purchase Of Investment | 2,914 | -1,946 | N/A | N/A | N/A |
| Other Investing Activity | 359 | 297 | 115 | 40 | -49,508 |
| Investing Cash Flow | $13,406 | $8,347 | $6,772 | $1,313 | $-49,595 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,764 | 1,200 | 1,200 | 1,200 | N/A |
| Other Financing Activity | -252 | -167 | -110 | -55 | 68,488 |
| Financing Cash Flow | $1,512 | $1,033 | $1,090 | $1,145 | $68,488 |
| Exchange Rate Effect | -24 | -12 | -11 | -32 | 61 |
| Beginning Cash Position | 11,247 | 11,247 | 11,247 | 11,247 | 4,385 |
| End Cash Position | 10,890 | 9,117 | 10,540 | 10,195 | 11,247 |
| Net Cash Flow | $-357 | $-2,130 | $-707 | $-1,052 | $6,862 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,877 | -11,334 | -8,558 | -3,323 | -12,092 |
| Capital Expenditure | -115 | -115 | -109 | -27 | N/A |
| Free Cash Flow | -14,992 | -11,449 | -8,667 | -3,350 | -12,092 |